Mitralign, Inc. Successfully Completes First Human Case
Published: Feb 05, 2008
TEWKSBURY, Mass.--(BUSINESS WIRE)--Mitralign, Inc. announced today that it successfully performed its first implantation of the Mitralign Percutaneous Annuloplasty System(TM) for mitral valve repair at French Hospital in Asuncion, Paraguay. The patient was treated by an experienced medical team led by Adrian Ebner, MD of the French Hospital and Lutz Buellesfeld, MD of Helios Heart Center, Siegburg, Germany. The Mitralign System was able to remodel the valve and reduce the patient's mitral regurgitation from 3+ to 2+, 24 hours after the procedure based on core lab assessment. The patient spent less than 48 hours in the hospital after the procedure and continues to do well at home.